Comparative tolerability of treatments for inflammatory bowel disease.
作者： Robert B. Stein , Stephen B. Hanauer
DOI: 10.2165/00002018-200023050-00006
关键词: Disease 、 Immunology 、 Gastroenterology 、 Infliximab 、 Inflammatory bowel disease 、 Internal medicine 、 Medicine 、 Sulfasalazine 、 Ulcerative colitis 、 Antibacterial agent 、 Tacrolimus 、 Tolerability
摘要: Despite limited understanding of therapeutic aetiopathogenesis ulcerative colitis and Crohn’s disease, there is a strong evidence base for the efficacy pharmacological biological therapies. It equally important to recognise toxicity medical armamentarium inflammatory bowel disease (IBD).
springer.com
sci-hub.se 参考文章(200)
Bret Fulton, Anthony Markham, Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs. ,vol. 51, pp. 278- 298 ,(1996) , 10.2165/00003495-199651020-00007
K. M. Das, M. A. Eastwood, J. P. A. McManus, W. Sircus, Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. The New England Journal of Medicine. ,vol. 289, pp. 491- 495 ,(1973) , 10.1056/NEJM197309062891001
A.K. Trull, K.K.C. Tan, J. Uttridge, T. Bauer, G.J.M. Alexander, N.V. Jamieson, Cyclosporin absorption from microemulsion formulation in liver transplant recipient The Lancet. ,vol. 341, pp. 433- 433 ,(1993) , 10.1016/0140-6736(93)93025-V
R. HAMEDANI, R. D. FELDMAN, B. G. FEAGAN, Review article: Drug development in inflammatory bowel disease: budesonide--a model of targeted therapy. Alimentary Pharmacology & Therapeutics. ,vol. 11, pp. 98- 108 ,(2010) , 10.1111/J.1365-2036.1997.TB00814.X
I D Griffiths, S P Kane, Sulphasalazine-induced lupus syndrome in ulcerative colitis. BMJ. ,vol. 2, pp. 1188- 1189 ,(1977) , 10.1136/BMJ.2.6096.1188
WIL B. NELP, Acute Pancreatitis Associated with Steroid Therapy Archives of Internal Medicine. ,vol. 108, pp. 702- 710 ,(1961) , 10.1001/ARCHINTE.1961.03620110042007
L Staerk Laursen, M Stokholm, K Bukhave, J Rask-Madsen, K Lauritsen, Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut. ,vol. 31, pp. 1271- 1276 ,(1990) , 10.1136/GUT.31.11.1271
David L. Paterson, Nina Singh, Annunziata Panebianco, Cheryl F. Wannstedt, Marilyn M. Wagener, Timothy Gayowski, Ignazio R. Marino, Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil Transplantation. ,vol. 66, pp. 593- 598 ,(1998) , 10.1097/00007890-199809150-00007
P Larochelle, P Du Souich, E Bolte, J Lelorier, R Goyer, Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application. Clinical Pharmacology & Therapeutics. ,vol. 33, pp. 343- 350 ,(1983) , 10.1038/CLPT.1983.43
Young-In Kim, Short‐Chain Fatty Acids in Ulcerative Colitis Nutrition Reviews. ,vol. 56, pp. 17- 24 ,(2009) , 10.1111/J.1753-4887.1998.TB01654.X